Arca Biopharma | ABIO - Capital Social e Reservas





Capital Social e Reservas Alterar Data
Alterity Therapeutics Limited AUD 36.21M 18.58M 2025-12
Amgen USD 11.69B 2.5B 2026-06
Arca Biopharma USD 1.11B 627.83M 2026-06
Biogen USD 18.85B 196.3M 2026-06
Brainstorm Cell Therapeutics USD -11.6M 588K 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Capricor Therapeutics USD 246.22M 32.48M 2026-06
Cipla INR 344.32B 15.13B 2026-03
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 95.35M 7.38M 2026-03
CSL USD 18.66B 2.75B 2025-12
Cytokinetics USD -173.49M 653.08M 2026-06
Daiichi Sankyo JPY 1.7T 38.53B 2026-06
Gilead Sciences USD 11.74B 11.77B 2026-06
GlaxoSmithKline GBP 17.64B 223M 2026-06
Grifols EUR 6.21B 133.12M 2025-12
Laboratory Of America USD 8.61B 121.8M 2026-06
Myriad Genetics USD 303.9M 33.5M 2026-06
Otsuka Holdings JPY 3.24T 131.63B 2026-06
Pfizer USD 85.19B 4.91B 2026-06
United Therapeutics USD 6.4B 499.2M 2026-06